Aandeel SEQUA SEQUANA MEDICAL N.V.
Toevoegen aan een lijst
Om deze functie te gebruiken moet u een klant of lid zijn.
InloggenRegistreren

Andere talen Sequana Medical N.V.

Aandelen

SEQUA

BE0974340722

Beurs gesloten - Euronext Bruxelles
Andere beurzen
 17:35:23 09-05-2024 		Variatie 5 dagen Verschil t.o.v. 1 jan (%)
1,49 EUR +2,76% Intraday-grafiek van Sequana Medical N.V. +4,93% -62,75%
03/05 Brussel hoger het weekend in AM
11/04 Brusselse beurs opent aarzelend AM

Andere talen

Zoeken op
Resultaten bekijken
Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!
Gratis inschrijven
Sequana Medical N : Draft Remuneration Policy
Advice of the ad hoc committee of independent directors in accordance with Article 7:179 of the Belgian Companies and Associations Code
Report of the Board of Directors in accordance with Articles 7:179 and 7:197 of the Belgian Companies and Associations Code
Special Report of the Board of Directors in accordance with Article 7:199 of the Belgian Companies and Associations Code
Sequana Medical N : Report of the Board of Directors on the annual accounts for the year ended 31 December 2023
Sequana Medical N : Statutory annual accounts for the year ended 31 December 2023
Sequana Medical N : Statutory auditor’s report on the consolidated accounts for the year ended 31 December 2023
Sequana Medical N : Statutory auditor’s report on the annual accounts for the year ended 31 December 2023
Sequana Medical Announces Strong Data from DSR Proof-of-Concept Studies in Heart Failure Published in European Journal of Heart Failure
Sequana Medical NV Reports Earnings Results for the Full Year Ended December 31, 2023
Sequana Medical NV Announces Three Month Follow-Up Data from MOJAVE Non- Randomized Cohort Confirming Significant Improvement in Diuretic Response and Virtual Elimination of Loop Diuretics Following DSR Therapy
Sequana Medical Raises EUR11.5 Million via Share Placement
Sequana Medical's Premarket Application for Alfapump Accepted by US FDA; Shares Rise
Sequana Medical Receives New US Reimbursement Codes for Alfapump System
Sequana Medical submits Premarket Approval application to US FDA for alfapump in recurrent or refractory ascites due to liver cirrhosis
Belgium's Sequana Medical Seeks US FDA Premarket Approval for Liver Ascites Treatment Device
Sequana Medical N : announces positive data from non-randomized cohort in US Phase 1/2a MOJAVE study of DSR® 2.0 for treatment of heart failure
Sequana Medical NV Announces Positive Data from Non- Randomized Cohort in US Phase 1/2a MOJAVE Study of DSR® 2.0 for Treatment of Heart Failure
Sequana Medical NV Appoints Ids Van Der Weij as Non-Executive Director
Certain Shares of Sequana Medical NV are subject to a Lock-Up Agreement Ending on 22-OCT-2023.
Geen resultaten voor deze zoekopdracht
Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Filters

Zoeken op

Datum van publicatie

Sinds de

Tot

  1. Beurs
  2. Aandelen
  3. Koers SEQUA
  4. Nieuws Sequana Medical N.V.
  5. Andere talen